Analyst Sentiment Sours on Texas Instruments Amid Weakening Outlook

Market analysts are growing increasingly cautious about semiconductor manufacturer Texas Instruments, with multiple firms revising their ratings and price targets downward. The consensus has shifted to a “Hold” position as concerns mount over slower-than-anticipated demand recovery and mounting margin pressures.

Quarterly Results Spark Concerns

The catalyst for this wave of analyst skepticism emerged from Texas Instruments’ October third-quarter earnings report. While the company met expectations with earnings per share of $1.48 and revenue of $4.74 billion, its guidance for the current quarter fell substantially below market projections.

Management’s fourth-quarter forecast anticipates revenue between $4.22 billion and $4.58 billion, with EPS expected to range from $1.13 to $1.39. Particularly troubling to market observers is the projected gross margin decline to approximately 54.8% for the December quarter—potentially reaching its lowest level in nearly a decade.

Price Target Reductions Multiply

Several prominent financial institutions have responded to these developments by adjusting their assessments. Mizuho maintained its “Underperform” rating while reducing its price target to $145. Bernstein followed suit, cutting its target to $160. Both firms cited disappointing forward guidance and a more gradual demand recovery as primary concerns.

Should investors sell immediately? Or is it worth buying Texas Instruments?

Even typically optimistic TD Cowen found itself compelled to moderate its outlook, trimming its price objective from $210 to $200. The firm pointed to seasonal headwinds, increased depreciation expenses, and underutilization of manufacturing capacity as factors squeezing profitability.

Long-Term Strengths Provide Counterbalance

Despite these near-term challenges, Texas Instruments maintains several strategic advantages. The company recently demonstrated its financial resilience by raising its quarterly dividend by 4% to $1.42 per share, signaling confidence in its sustained cash generation capabilities.

Additionally, the chipmaker is making substantial investments in domestic manufacturing capacity, committing over $60 billion to expand U.S. production facilities. This strategic initiative received significant support through $1.6 billion in CHIPS Act funding. These long-term investments aim to strengthen supply chain security and achieve lower production costs over time.

The critical question facing investors is whether these future-oriented investments can sufficiently offset current margin compression and hesitant customer demand. The company’s next earnings report in January will provide crucial insight into whether Texas Instruments has reached its cyclical trough or if the downward trend will persist.